DLX6 and endometrial cancer: The aforementioned results indicate that transcription factor E2F1 is enriched in DLX6‐AS1 promoter region, facilitating the DLX6‐AS1 expression in endometrial cancer tissue and cells in association with histological classification and TNM stage.